HTFL

시장 영업 전: 34.49

Heartflow Inc (HTFL)

개요 뉴스 가격 이력 토론 예측

Relative Volume:

Heartflow Inc Stock (HTFL) Company Profile

Heartflow Inc

Healthcare (1150)

650-241-1221

331 E EVELYN AVENUE, MOUNTAIN VIEW

최신 SEC 제출 서류

HTFL's Discussions on Twitter

HTFL을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
HTFL Heartflow Inc	34.49	2.99B	0	0	0	0.00
VEEV Veeva Systems Inc	277.94	45.70B	2.97B	809.93M	1.33B	4.87
TEM Tempus Ai Inc	79.23	14.62B	803.32M	-709.10M	-212.68M	-7.8003
DOCS Doximity Inc	74.27	13.84B	550.17M	201.35M	232.07M	1.00
HQY Healthequity Inc	94.26	8.09B	1.15B	96.70M	-161.99M	1.09
WAY Waystar Holding Corp	37.04	6.58B	906.14M	-52.62M	89.62M	-0.3621

Heartflow Inc Stock (HTFL) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-09-02	개시	Canaccord Genuity	Buy
2025-09-02	개시	JP Morgan	Overweight
2025-09-02	개시	Morgan Stanley	Equal-Weight
2025-09-02	개시	Piper Sandler	Overweight
2025-09-02	개시	Stifel	Buy

Heartflow Inc 주식(HTFL)의 최신 뉴스

Heartflow Inc (HTFL) 재무 분석

Heartflow Inc (HTFL)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.

Heartflow Inc (HTFL)

Heartflow Inc Stock (HTFL) Company Profile

HTFL을(를) 다른 주식과 비교

Heartflow Inc Stock (HTFL) Upgrades & Downgrades

Heartflow Inc 주식(HTFL)의 최신 뉴스

Why HeartFlow Stock Rocketed 14% Higher Today - Yahoo Finance

FDA clears Heartflow’s next-gen plaque analysis - BioWorld MedTech

Heartflow (NASDAQ:HTFL) Shares Up 10% Following Analyst Upgrade - MarketBeat

CCORF Maintains Heartflow(HTFL.US) With Buy Rating, Maintains Target Price $39 - 富途牛牛

Heartflow secures FDA clearance for updated plaque analysis platform - Yahoo Finance

Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform - BioSpace

Heartflow (NASDAQ:HTFL) Given New $39.00 Price Target at Canaccord Genuity Group - Defense World

FDA clears Heartflow’s AI plaque analysis tool, Cigna to cover it - Investing.com

FDA clears Heartflow’s AI plaque analysis tool, Cigna to cover it By Investing.com - Investing.com South Africa

Heartflow stock rises after FDA clearance for Next Gen Plaque Analysis By Investing.com - Investing.com Nigeria

Heartflow stock rises after FDA clearance for Next Gen Plaque Analysis - Investing.com UK

Heartflow announces FDA 510(k) clearance and launch of next generation Heartflow Plaque Analysis platform - MarketScreener

Heartflow Announces FDA 510(K) Clearance And Launch Of Next Generation Heartflow Plaque Analysis Platform - TradingView

Heartflow Receives FDA 510(k) Clearance for Next-Gen Heartflow Plaque Analysis Platform - MarketScreener

Cigna (CI) to Cover Heartflow's Newly Approved Technology - GuruFocus

FDA Clears Heartflow Coronary Plaque Technology - MarketScreener

Heartflow announces FDA clearance of plaque analysis algorithm, Cigna coverage - TipRanks

95% Accuracy vs Gold Standard: HeartFlow's Revolutionary AI Heart Disease Platform Wins FDA Approval - Stock Titan

Heartflow (NASDAQ:HTFL) Stock Price Down 5.2% After Earnings Miss - MarketBeat

Canaccord Genuity raises Heartflow stock price target to $39 on FFRct growth - Investing.com Nigeria

Canaccord Genuity Group Issues Positive Forecast for Heartflow (NASDAQ:HTFL) Stock Price - MarketBeat

Heartflow price target raised to $39 from $35 at Canaccord - TipRanks

Heartflow (NASDAQ:HTFL) Issues Earnings Results, Misses Expectations By $1.26 EPS - MarketBeat

AI-Enabled Heart Diagnostics Put HeartFlow (HTFL) in the Spotlight - MSN

HeartFlow: Q2 Earnings Snapshot - New Haven Register

HeartFlow, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener

Heartflow, Inc. SEC 10-Q Report - TradingView

Stocks Generating Improved Relative Strength: Heartflow - MSN

Heartflow Completes US$364 Million Upsized IPO - Global Legal Chronicle

Heartflow, Inc.'s (NASDAQ:HTFL) Quiet Period Will Expire on September 17th - MarketBeat

HeartFlow, Inc.: Balancing Impressive Growth with Strategic Challenges – A Hold Recommendation - TipRanks

Heartflow (NASDAQ:HTFL) Shares Gap UpHere's Why - MarketBeat

HeartFlow Releases Investor Presentation at Healthcare Conference - TipRanks

Heartflow Incexpects Q2 2025 revenue of $43.4 millionSEC filing - MarketScreener

HeartFlow (HTFL): Evaluating Valuation After Recent Share Price Surge Without a Clear Catalyst - Yahoo Finance

Heartflow (NASDAQ:HTFL) Stock Rating Upgraded by Zacks Research - MarketBeat

Med-tech financings hold steady through August, IPOs rebound - BioWorld MedTech

Heartflow, Inc. (NASDAQ:HTFL) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Morgan Stanley Initiates Coverage on Heartflow (NASDAQ:HTFL) - MarketBeat

Heartflow (NASDAQ:HTFL) Coverage Initiated at JPMorgan Chase & Co. - MarketBeat

VentriPoint: The Echo Play In AI Cardiac Imaging's Trillion-Dollar Convergence - Barchart.com

Heartflow (NASDAQ:HTFL) Coverage Initiated by Analysts at Canaccord Genuity Group - Defense World

Stifel initiates coverage on Heartflow stock with Buy rating, $35 target - Investing.com India

Heartflow, Inc. shares rise 2.70% after-hours following positive analyst ratings from Morgan Stanley and Stifel. - AInvest

Heartflow announces pricing of upsized IPO - MSN

Wall Street analysts initiate AI diagnostic co HeartFlow with bullish views - Investing.com Canada

Morgan Stanley initiates coverage on Heartflow stock with Equalweight rating - Investing.com India

Canaccord Genuity initiates Heartflow stock with Buy rating on AI cardiac tools - Investing.com

Top 5 Stock Initiation Reports for Tuesday: Firefly Aerospace, HeartFlow, WhiteFiber, Tempus AI, and Penumbra - AInvest

Morgan Stanley initiates coverage on Heartflow stock with Equalweight rating By Investing.com - Investing.com Australia

Piper Sandler initiates Heartflow stock with Overweight rating on AI potential - Investing.com Nigeria

Heartflow Inc (HTFL) 재무 분석

매출

순이익

현금흐름

주당 순 이익

HTFL과 유사한 종목